Bank Of America Corp Cin Cor Pharma, Inc. Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$10.75 - $29.84 $149,210 - $414,179
13,880 Added 136.99%
24,012 $295,000
Q3 2022

Nov 14, 2022
SELL
$19.9 - $38.94 $323,474 - $632,969
-16,255 Reduced 61.6%
10,132 $332,000
Q2 2022

Aug 12, 2022
BUY
$13.67 - $25.74 $233,551 - $439,767
17,085 Added 183.67%
26,387 $497,000
Q1 2022

May 16, 2022
BUY
$14.13 - $28.49 $131,437 - $265,013
9,302 New
9,302 $163,000

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email